Patients News | pharmaphorum

News

Early result backs Regeneron’s deafness gene therapy

Regeneron’s gene therapy for a profound form of deafness affecting children, DB-OTO, has shown the first signs that it can improve hearing in a clinical trial.

News

NICE backs pump-based Parkinson’s drug from AbbVie

A therapy for Parkinson’s disease that can be delivered by a 24-hour subcutaneous infusion pump has been recommended for use by the NHS and could be an option for hundreds

News

GSK targets younger age group with RSV jab Arexvy

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s

News

AZ seeks FDA okay for first self-administered flu vaccine

The FDA has started a review of an extension to the labelling for AstraZeneca’s influenza vaccine FluMist Quadrivalent which would allow it to be administered by patients

News

Ipsen to refile Alagille drug after EU blocks orphan status

Ipsen has said that it plans to file a new marketing application for its treatment for itch in Alagille syndrome (ALGS), Bylvay, after failing to persuade an EMA committee

News

Amwell, Leidos win $180m US military digital health contract

Faced with escalating costs, the US Defense Health Agency (DHA) is seeking a digital solution to the problem of managing chronic health conditions – and has turned to tele

Early result backs Regeneron’s deafness gene therapy

NICE backs pump-based Parkinson’s drug from AbbVie

GSK targets younger age group with RSV jab Arexvy

AZ seeks FDA okay for first self-administered flu vaccine

Ipsen to refile Alagille drug after EU blocks orphan status

Amwell, Leidos win $180m US military digital health contract

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks